Literature DB >> 21552166

Changes in self-reported hot flashes and their association with concurrent changes in insomnia symptoms among women with breast cancer.

Marie-Hélène Savard1, Josée Savard, Claudia Trudel-Fitzgerald, Hans Ivers, Catherine Quesnel.   

Abstract

OBJECTIVE: The aim of this study was to assess longitudinally the relationship between hot flashes and insomnia symptoms in women receiving adjuvant treatments for breast cancer.
METHODS: Fifty-eight participants completed a 7-day daily diary assessing hot flashes, the Menopause-Specific Quality of Life Questionnaire, and the Insomnia Severity Index, before and after chemotherapy or radiotherapy and at a 3-month follow-up evaluation.
RESULTS: A first canonical correlation analysis (n = 55) revealed a marginally significant relationship between pretreatment versus posttreatment change scores in hot flashes and sleep (R = 0.39), and a second analysis (n = 51) showed a significant relationship between posttreatment and follow-up changes in hot flash activity and sleep (R = 0.59).
CONCLUSIONS: These results show that increases in vasomotor symptoms occurring within the few months after the termination of initial adjuvant treatments for breast cancer are significantly associated with concurrent increases in insomnia symptoms and vice versa.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21552166     DOI: 10.1097/gme.0b013e31820db6a1

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  8 in total

1.  Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial.

Authors:  Sheila N Garland; Sharon X Xie; Qing Li; Christina Seluzicki; Coby Basal; Jun J Mao
Journal:  Menopause       Date:  2017-05       Impact factor: 2.953

2.  Actigraphy and Sleep Diary Measurements in Breast Cancer Survivors: Discrepancy in Selected Sleep Parameters.

Authors:  Camille M Moore; Sarah J Schmiege; Ellyn E Matthews
Journal:  Behav Sleep Med       Date:  2014-08-12       Impact factor: 2.964

3.  Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer.

Authors:  Christina Van Onselen; Steven M Paul; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Bruce Cooper; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2012-08-24       Impact factor: 3.612

4.  Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.

Authors:  Brian D Gonzalez; Brent J Small; Mallory G Cases; Noelle L Williams; Mayer N Fishman; Paul B Jacobsen; Heather S L Jim
Journal:  Cancer       Date:  2017-10-26       Impact factor: 6.860

5.  Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.

Authors:  Eleanor Mann; Melanie J Smith; Jennifer Hellier; Janet A Balabanovic; Hisham Hamed; Elizabeth A Grunfeld; Myra S Hunter
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

Review 6.  Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Authors:  Julie L Otte; Janet S Carpenter; Shalini Manchanda; Kevin L Rand; Todd C Skaar; Michael Weaver; Yelena Chernyak; Xin Zhong; Christele Igega; Carol Landis
Journal:  Cancer Med       Date:  2014-11-30       Impact factor: 4.452

Review 7.  Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic review.

Authors:  Winnie K W So; Bernard M H Law; Marques S N Ng; Xiaole He; Dorothy N S Chan; Carmen W H Chan; Alexandra L McCarthy
Journal:  Cancer Med       Date:  2021-03-21       Impact factor: 4.452

8.  Hot flashes, insomnia, and the reproductive stages: a cross-sectional observation of women from the EPISONO study.

Authors:  Helena Hachul; Laura Siqueira Castro; Andréia Gomes Bezerra; Gabriel Natan Pires; Dalva Poyares; Monica Levy Andersen; Lia Rita Bittencourt; Sergio Tufik
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.